139 related articles for article (PubMed ID: 7542392)
1. Low responsiveness to agents evoking 5-HT2 receptor-mediated behaviors in Sardinian alcohol-preferring rats.
Ciccocioppo R; Panocka I; Stefanini E; Gessa GL; Massi M
Pharmacol Biochem Behav; 1995 May; 51(1):21-7. PubMed ID: 7542392
[TBL] [Abstract][Full Text] [Related]
2. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
3. Selective agonists at NK3 tachykinin receptors inhibit alcohol intake in Sardinian alcohol-preferring rats.
Ciccocioppo R; Panocka I; Pompei P; De Caro G; Massi M
Brain Res Bull; 1994; 33(1):71-7. PubMed ID: 7506113
[TBL] [Abstract][Full Text] [Related]
4. Effects of antidepressant drug combinations on cortical 5-HT2 receptors and wet-dog shakes in rats.
Koshikawa F; Koshikawa N; Stephenson JD
Eur J Pharmacol; 1985 Dec; 118(3):273-81. PubMed ID: 2935412
[TBL] [Abstract][Full Text] [Related]
5. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
Fone KC; Johnson JV; Bennett GW; Marsden CA
Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
[TBL] [Abstract][Full Text] [Related]
6. The tachykinin NH2-senktide inhibits alcohol intake in alcohol-preferring rats.
Perfumi M; Polidori C; Pompei PL; De Caro G; Massi M
Pharmacol Biochem Behav; 1991 Apr; 38(4):881-7. PubMed ID: 1714609
[TBL] [Abstract][Full Text] [Related]
7. Behavioral responses to stress following central and peripheral injection of the 5-HT(2) agonist DOI.
Hawkins MF; Uzelac SM; Baumeister AA; Hearn JK; Broussard JI; Guillot TS
Pharmacol Biochem Behav; 2002 Oct; 73(3):537-44. PubMed ID: 12151027
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of the behavioural syndrome induced by the NK-3 tachykinin agonist senktide in rodents: evidence for mediation by endogenous 5-HT.
Stoessl AJ; Dourish CT; Iversen SD
Brain Res; 1990 May; 517(1-2):111-6. PubMed ID: 1695859
[TBL] [Abstract][Full Text] [Related]
9. 5-HT2 receptor antagonists do not reduce ethanol preference in Sardinian alcohol-preferring (sP) rats.
Panocka I; Ciccocioppo R; Pompei P; Massi M
Pharmacol Biochem Behav; 1993 Dec; 46(4):853-6. PubMed ID: 7508629
[TBL] [Abstract][Full Text] [Related]
10. Identification of the central tachykinin receptor subclass involved in substance P-induced cardiovascular and behavioral responses in conscious rats.
Itoi K; Tschöpe C; Jost N; Culman J; Lebrun C; Stauss B; Unger T
Eur J Pharmacol; 1992 Sep; 219(3):435-44. PubMed ID: 1385176
[TBL] [Abstract][Full Text] [Related]
11. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors.
Rittenhouse PA; Bakkum EA; Van de Kar LD
J Pharmacol Exp Ther; 1991 Oct; 259(1):58-65. PubMed ID: 1920135
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
Cellier E; Barbot L; Regoli D; Couture R
Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
[TBL] [Abstract][Full Text] [Related]
13. The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats.
Stoessl AJ; Dourish CT; Iversen SD
Br J Pharmacol; 1988 Jun; 94(2):285-7. PubMed ID: 2456111
[TBL] [Abstract][Full Text] [Related]
14. Autoradiographic analysis of 5-HT2A binding sites in the brain of Sardinian alcohol-preferring and nonpreferring rats.
Ciccocioppo R; Angeletti S; Colombo G; Gessa G; Massi M
Eur J Pharmacol; 1999 May; 373(1):13-9. PubMed ID: 10408247
[TBL] [Abstract][Full Text] [Related]
15. Further evidence for an anomalous regulation of cortical 5-HT2 receptors: studies with 5-HT precursors.
Koshikawa N; Koshikawa F; Stephenson JD
Eur J Pharmacol; 1990 Mar; 178(3):365-9. PubMed ID: 2340865
[TBL] [Abstract][Full Text] [Related]
16. Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.
Done CJ; Sharp T
Br J Pharmacol; 1992 Sep; 107(1):240-5. PubMed ID: 1422575
[TBL] [Abstract][Full Text] [Related]
17. Noradrenergic denervation alters serotonin2-mediated behavior but not serotonin2 receptor number in rats: modulatory role of beta adrenergic receptors.
Eison AS; Yocca FD; Gianutsos G
J Pharmacol Exp Ther; 1988 Aug; 246(2):571-7. PubMed ID: 2900327
[TBL] [Abstract][Full Text] [Related]
18. L-5-HTP facilitates the electrically stimulated flexor reflex in pithed rats: evidence for 5-HT2-receptor mediation.
Skarsfeldt T; Arnt J; Hyttel J
Eur J Pharmacol; 1990 Feb; 176(2):135-42. PubMed ID: 1968846
[TBL] [Abstract][Full Text] [Related]
19. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
[TBL] [Abstract][Full Text] [Related]
20. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
Eison AS; Eison MS; Yocca FD; Gianutsos G
Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
